EUVIMEDOpdag EUVIMED
Kohortenstudie

Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis

Xinru Ran, Fan Wu iD, Zihui Wang iD, Haiqing Li, Zhishan Deng, Qiaorui Zhou, Huajing Yang iD, Youlan Zheng, Ningning Zhao, Cuiqiong Dai iD, Gaoying Tang, Xiaohui Wu and 12 more

Respirology · 2025

DOI: 10.1111/resp.70099 ↗

At a glance

Kohortenstudie in Respirology, 2025. Written by Xinru Ran and 23 co-authors. Institution: Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Gu…. Major MEDLINE topics: Pulmonary Disease, Chronic Obstructive, Matrix Metalloproteinase 9, Lung. Cited 1 times so far (Crossref); 37 references. Funded by: The Foundation of Guangzhou National Laboratory, The Foundation of Guangzhou Basic and Applied Basic Research Scheme, The Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Objective The imbalance in proteases/antiproteases caused by inflammation contributes to COPD, and matrix metalloproteinase‐9 (MMP‐9) may play an important role. Therefore, we aimed to investigate the associations of MMP‐9 with respiratory health outcomes.

Methods

This study was conducted in two parts. Firstly, we performed a prospective cohort study to investigate the association of circulating MMP‐9 and respiratory health outcomes. Participants completed a questionnaire, spirometry, and chest CT, and provided blood samples at baseline. Follow‐up visits were conducted annually. Study outcomes were the development of spirometry‐defined COPD, lung function decline, and exacerbations. Secondly, we performed a two‐sample Mendelian randomisation (MR) study to evaluate the causal effect between genetically predicted MMP‐9 expression and lung function.

Results

Overall, 1328 participants were included in the baseline analysis, and 1034 (78%) completed the 2‐year follow‐up. Higher plasma MMP‐9 at baseline was associated with chronic respiratory symptoms, severe emphysema, and air trapping. During the 2‐year follow‐up, each SD increase in plasma MMP‐9 was associated with accelerated decline in pre‐bronchodilator FEV 1 (adjusted difference = 6.4 [95% CI: 0.7–12.1] mL/year) and FVC (adjusted difference = 18.0 [95% CI: 7.6–28.5] mL/year), and a higher exacerbation incidence. In participants with normal spirometry at baseline, higher plasma MMP‐9 was associated with progression to spirometry‐defined COPD (adjusted OR = 1.93, 95% CI: 1.05–3.57). A MR study demonstrated similar results toward negative associations of genetically predicted MMP‐9 expression with FEV 1 and FVC.

Conclusion

The longitudinal cohort and MR study provide evidence that MMP‐9 might play a causative role in lung function decline and spirometry‐defined COPD development. image

Subjects

MeSH terms (MEDLINE)

Pulmonary Disease, Chronic ObstructiveMatrix Metalloproteinase 9LungHumansMaleMendelian Randomization AnalysisProspective StudiesFemaleMiddle AgedAgedSpirometryDisease ProgressionForced Expiratory VolumeRespiratory Function TestsBiomarkers

Author keywords

Mendelian randomisationchronic obstructive pulmonary diseasecohort studylung functionmatrix metalloproteinase‐9

Substances

Matrix Metalloproteinase 9MMP9 protein, humanBiomarkers

Authors and institutions

  • Guangzhou Medical University-Guangzhou Institute of Biomedicine and Health (GMU-GIBH) Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China.
  • State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease & National Center for Respiratory Medicine & Guangzhou Institute of Respiratory Health, The First Affiliated Hospit…
  • Guangzhou National Laboratory, Guangzhou, China.
  • The First Clinical College of Guangzhou Medical University, Guangzhou, China.

ORCID profiles: Fan Wu, Zihui Wang, Huajing Yang, Cuiqiong Dai, Lifei Lu, Kunning Zhou, Pixin Ran, Yumin Zhou

Funding

  • The Foundation of Guangzhou National Laboratory
  • The Foundation of Guangzhou Basic and Applied Basic Research Scheme
  • The Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease
  • The National Natural Science Foundation of China
  • Major Clinical Research Project of Guangzhou Medical University's Scientific Research Capability Improvement Plan
  • the Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China

Cite

APA

Ran, X., Wu, F., Wang, Z., Li, H., Deng, Z., Zhou, Q., Yang, H., Zheng, Y., Zhao, N., Dai, C., Tang, G., Wu, X., Wan, Q., Peng, J., Lu, L., Zhou, K., Bai, G., Cui, J., Zhang, Y., …, & Zhou, Y. (2025). Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis. Respirology. https://doi.org/10.1111/resp.70099

Vancouver

Ran X, Wu F, Wang Z, Li H, Deng Z, Zhou Q, et al. Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis. Respirology. 2025. doi:10.1111/resp.70099

BibTeX
@article{Ran2025,
  author = {Ran, Xinru and Wu, Fan and Wang, Zihui and Li, Haiqing and Deng, Zhishan and Zhou, Qiaorui and Yang, Huajing and Zheng, Youlan and Zhao, Ningning and Dai, Cuiqiong and Tang, Gaoying and Wu, Xiaohui and Wan, Qi and Peng, Jieqi and Lu, Lifei and Zhou, Kunning and Bai, Ge and Cui, Jieda and Zhang, Yang and Ke, Maomao and Han, Wenya and Sun, Ruiting and Ran, Pixin and Zhou, Yumin},
  title = {Elevated MMP ‐9 Is Associated With Accelerated Lung Function Decline and COPD Development: A Prospective Cohort Study and Mendelian Randomisation Analysis},
  journal = {Respirology},
  year = {2025},
  doi = {10.1111/resp.70099}
}
Start for free →